These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro. Matsuo O, Rijken DC, Collen D. Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339 [Abstract] [Full Text] [Related]
6. [Blood coagulating properties of immobilized proteases]. Zubairov DM, Zinkevich OD. Vopr Med Khim; 1976 Jun 30; 22(2):187-91. PubMed ID: 140525 [Abstract] [Full Text] [Related]
7. Immobilization of plasminogen activator, urokinase, on nylon. Sugitachi A, Takagi K, Imaoka S, Kosaki G. Thromb Haemost; 1978 Apr 30; 39(2):426-36. PubMed ID: 580991 [Abstract] [Full Text] [Related]
13. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase. Ueno T, Kobayashi N, Maekawa T. Thromb Haemost; 1979 Oct 31; 42(3):885-94. PubMed ID: 505403 [Abstract] [Full Text] [Related]
14. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: an improved fibrinolytic agent targeted to phospholipid-containing thrombi. Tanaka K, Einaga K, Tsuchiyama H, Tait JF, Fujikawa K. Biochemistry; 1996 Jan 23; 35(3):922-9. PubMed ID: 8547274 [Abstract] [Full Text] [Related]
15. The in vitro and in vivo behavior of urokinase immobilized onto collagen-synthetic polymer composite material. Watanabe S, Shimizu Y, Teramatsu T, Murachi T, Hino T. J Biomed Mater Res; 1981 Jul 23; 15(4):553-63. PubMed ID: 7024280 [Abstract] [Full Text] [Related]
16. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin]. Andreenko GV, Serebriakova TN, Shimonaeva EE, Liutova LV, Karabasova MA. Nauchnye Doki Vyss Shkoly Biol Nauki; 1983 Jul 23; (3):51-4. PubMed ID: 6342687 [Abstract] [Full Text] [Related]
19. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y. J Cardiol; 1993 Jul 23; 23(4):335-41. PubMed ID: 8064582 [Abstract] [Full Text] [Related]
20. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase. Theiss W, Asbeck F, Kriessmann A, Trübestein G, Knoch K, de Swart CA, Marbert GA, van de Loo JC. Thromb Haemost; 1983 Oct 31; 50(3):664-8. PubMed ID: 6196852 [Abstract] [Full Text] [Related] Page: [Next] [New Search]